Antiangiogenic therapy decreases integrin expression in normalized tumor blood vessels

Cancer Research
Virginia J YaoDonald M McDonald

Abstract

Tumor blood vessels normalized by antiangiogenic therapy may provide improved delivery of chemotherapeutic agents during a window of time but it is unknown how protein expression in tumor vascular endothelial cells changes. We evaluated the distribution of RGD-4C phage, which binds alpha(v)beta(3), alpha(v)beta(5), and alpha(5)beta(1) integrins on tumor blood vessels before and after antiangiogenic therapy. Unlike the control phage, fd-tet, RGD-4C phage homed to vascular endothelial cells in spontaneous tumors in RIP-Tag2 transgenic mice in a dose-dependent fashion. The distribution of phage was similar to alpha(v)beta(3) and alpha(5)beta(1) integrin expression. Blood vessels that survived treatment with AG-013736, a small molecule inhibitor of vascular endothelial growth factor and platelet-derived growth factor receptors, had only 4% as much binding of RGD-4C phage compared with vessels in untreated tumors. Cellular distribution of RGD-4C phage in surviving tumor vessels matched the alpha(5)beta(1) integrin expression. The reduction in integrin expression on tumor vessels after antiangiogenic therapy raises the possibility that integrin-targeted delivery of diagnostics or therapeutics may be compromised. Efficacious delivery ...Continue Reading

References

Apr 1, 1980·Gene·A N ZacherG P Smith
Jan 1, 1993·Methods in Enzymology·G P Smith, J K Scott
Jan 1, 1996·Annual Review of Cell and Developmental Biology·E Ruoslahti
Jun 1, 1997·Nature Biotechnology·R PasqualiniE Ruoslahti
Feb 12, 1998·Proceedings of the National Academy of Sciences of the United States of America·D R SengerM Detmar
Aug 14, 1999·Science·F G Giancotti, E Ruoslahti
Sep 2, 1999·Nature Medicine·H M EllerbyR Pasqualini
Apr 3, 2001·Trends in Cardiovascular Medicine·H P Gerber, N Ferrara
Feb 21, 2002·Proceedings of the National Academy of Sciences of the United States of America·Markus Essler, Erkki Ruoslahti
Mar 14, 2002·The American Journal of Pathology·Shunichi MorikawaDonald M McDonald
May 29, 2002·Proceedings of the National Academy of Sciences of the United States of America·Ajeeta B DashD Gary Gilliland
Aug 15, 2002·Proceedings of the National Academy of Sciences of the United States of America·Jocelyn HolashJohn S Rudge
Sep 21, 2002·Proceedings of the National Academy of Sciences of the United States of America·Mikhail G KoloninWadih Arap
Dec 10, 2002·Trends in Molecular Medicine·Renata PasqualiniDonald M McDonald
Mar 15, 2003·Nature Reviews. Cancer·Erkki Ruoslahti
Dec 6, 2003·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Ralf ErberPeter Vajkoczy
Mar 5, 2004·Cancer Cell·Serena MarchiòWadih Arap
May 11, 2004·Nature Medicine·Mikhail G KoloninWadih Arap
Oct 12, 2004·Hematology/oncology Clinics of North America·Rosa Hwang, Judy Varner
Nov 17, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Timothy Whelan, Mark Levine
Nov 24, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Kristian Pietras, Douglas Hanahan
Nov 26, 2004·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·Judah Folkman
Feb 1, 2005·The American Journal of Pathology·Virginia J YaoRenata Pasqualini
Jun 24, 2005·The American Journal of Pathology·Patricia Parsons-WingerterDonald M McDonald

❮ Previous
Next ❯

Citations

Jul 3, 2010·American Journal of Physiology. Gastrointestinal and Liver Physiology·Rahul A Sheth, Umar Mahmood
Jul 21, 2007·Circulation Research·Ganapati H MahabeleshwarTatiana V Byzova
Dec 31, 2015·European Journal of Medicinal Chemistry·Jin ZhangLiang Ouyang
Jan 17, 2016·Journal of Controlled Release : Official Journal of the Controlled Release Society·Virginia J YaoRenata Pasqualini
Jul 23, 2013·Translational Research : the Journal of Laboratory and Clinical Medicine·Bin LiuJue Feng
Dec 18, 2008·Cancer·Anita TandleSteven K Libutti
Aug 30, 2008·Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [et Al.]·Han Hsi Wong, Nicholas R Lemoine
Apr 24, 2007·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Maria Luisa Balestrieri, Claudio Napoli
Jun 4, 2008·Annals of the New York Academy of Sciences·Peter Baluk, Donald M McDonald
Jul 30, 2014·Circulation Journal : Official Journal of the Japanese Circulation Society·Tatsuya NoguchiTakayuki Sato
Jul 15, 2017·Expert Opinion on Drug Safety·A FaggianoA Colao
Apr 4, 2018·Cancers·Mizuho Sato-DahlmanMasato Yamamoto

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bacteriophage: Phage Therapy

Phage therapy uses bacterial viruses (bacteriophages) to treat bacterial infections and is widely being recognized as an alternative to antibiotics. Here is the latest research.

Adhesion Molecules in Health and Disease

Cell adhesion molecules are a subset of cell adhesion proteins located on the cell surface involved in binding with other cells or with the extracellular matrix in the process called cell adhesion. In essence, cell adhesion molecules help cells stick to each other and to their surroundings. Cell adhesion is a crucial component in maintaining tissue structure and function. Discover the latest research on adhesion molecule and their role in health and disease here.

Arterial-Venous in Development & Disease

Arterial-venous development may play a crucial role in cardiovascular diseases. Here is the latest research.

Angiogenesis Inhibitors to Treat Cancer

Cancer treatments including angiogenesis inhibitors prevent tumor cells from receiving nutrients and oxygen. Here is the latest research on angiogenesis inhibitors for the treatment of cancer.

Adenoma, Islet Cell

Islet Cell Adenoma arises in the islet cells, which are insulin producing cells of the pancreas. These tumors can be either malignant or benign. Discover the latest research on Islet Cell Adenoma here.